More Evidence That Health Insurance Status Affects Survival of Patients With Cancer
August 10th 2016Patients with cancer who have Medicaid coverage or who are uninsured are more likely to be diagnosed later and receive improper treatment for cancer, according to two recent studies, and these factors can have an impact on their survival.
Optune Approval Expanded for Newly Diagnosed GBM Patients
October 6th 2015Optune (formally the NovoTTF-100A System) in combination with adjuvant temozolomide, has been approved by the FDA to treat patients newly diagnosed with glioblastoma multiforme (GBM) following surgery, chemotherapy, and radiation therapy.